Cynosure, Inc.

229 articles about Cynosure, Inc.

• 

  Money on the Move: SwanBio, Remix, Locus, Mirvie and More

  5/18/2022

  Recent funding saw support for a platform that selectively degrades DNA, software to help read mammograms and a company using corn genetics to develop cancer-targeting viruses.

• Cynosure Announces $60 Million Follow-on Investment from Clayton, Dubilier & Rice to Accelerate Growth

  5/17/2022

  Cynosure, LLC, a leader in medical aesthetics systems and technologies, announced today a new investment of $60 million from lead investor Clayton, Dubilier & Rice.

• Cynosure Enters into Partnership Agreement with Jeisys Medical Japan

  3/18/2022

  Cynosure LLC announced today that Cynosure KK (subsidiary of Cynosure LLC) has entered into a distribution partnership with Jeisys Medical KK (subsidiary of Jeisys Medical Inc.) in Japan.

• Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London

  5/17/2021

  Cynosure announced the grand opening of its new Cynosure Experience Centre in London.

• Kellie Teal-Guess Joins Cynosure as Chief Human Resources Officer

  2/1/2021

  Cynosure announced that Kellie Teal-Guess will join its Executive Leadership Team as the new Chief Human Resources Officer, effective immediately.

• Medical Device Industry Executive Mark Didio Joins Cynosure

  1/11/2021

  Proven Leader Brings Expertise in Cultivating Customer Insights to Expand Global Markets as New General Manager of Surgical

• Cynosure Nabs Marketing Expert Katie Cheng As New Chief Marketing Officer

  1/4/2021

  Cynosure announced today that Katie Cheng will join Cynosure as its new Chief Marketing Officer. With more than 25 years of diverse experience in consumer and professional brand and product marketing

• Cynosure Names MedTech Leader Sujat Sukthankar Executive Vice President of Research & Product Development

  10/19/2020

  Cynosure announced the appointment of Sujat Sukthankar , former VP of Platform Engineering at Becton Dickinson and Vice President of R&D at Boston Scientific, as the Company's Executive Vice President of Research & Product D

• Cynosure Names Medical Aesthetics Pioneer, Rafael Sierra Ph.D., R&D Advisor

  9/16/2020

  Former Chief Technology Officer Returns, Bringing 40+ Years of Expertise in Laser Design and Tissue Interaction, to Further Expand Portfolio of Science-Driven Innovation WESTFORD, Mass. , Sept. 16, 2020 /PRNewswire/ -- Cynosure announced today its former Chief Technology Officer, Rafael Sierra Ph.D., will once again join the Cynosure team as our R&D Advisor. A true

• New Cynosure Global Report Reveals Strong Consumer Appetite For Return to In-Office Aesthetic Treatments

  6/22/2020

  "The Return of Aesthetic Patients Post COVID-19" report  finds majority of consumers eager to resume treatments and suggests necessary practitioner steps to ensure patient confidence WESTFORD, Mass. , June 22, 2020 /PRNewswire/ -- Cynosure, a global leader in medical aesthetics, today unveiled "The Return of Aesthetic Patients Post COVID-19, " a multi-continent research s

• Cynosure Launches Elite iQ™ Aesthetic Workstation For Laser Hair Removal and Skin Revitalization in the United States, Europe and Australia

  6/1/2020

  The World's First Alexandrite-ND: YAG System Now Upgraded with Skintel®, The Industry's Only Melanin Reader™ For More Customized Laser Hair Removal Treatments For All Skin Types   [01-June-2020]   WESTFORD, Mass. , June 1, 2020 /PRNewswire/ -- Cynosure announced today the U.S., European and Australian launch of the Elite iQ ™  platform ,  the next generation of the Elite+

• 

  BioSpace Movers & Shakers, April 10

  4/10/2020

  Biopharma companies strengthen their leadership teams and boards with this week's Movers & Shakers.

• Cynosure Names David Long Global Chief Financial Officer

  4/8/2020

  Cynosure, LLC, a leader in medical aesthetics systems and technologies, announced today the appointment of David Long as the company's Chief Financial Officer, effective immediately. With more than 25 years of global financ

• Cynosure Launches Potenza™ Radiofrequency Microneedling Device Expanding Company's Growing Skin Revitalization Portfolio

  2/25/2020

  The world's first FDA-cleared four-mode radiofrequency microneedling system allows practitioners to deliver a variety of customized treatments on single device

• Hologic Completes Acquisition Of Cynosure

  3/22/2017

• Hologic Takes Out Cynosure in $1.65 Billion Deal

  2/14/2017

• Cynosure Achieves Record Quarterly Revenue Of $122.1 Million In The Fourth Quarter Of 2016, Up 19 Percent Year-Over-Year

  2/7/2017

• Cynosure Receives CFDA Clearance To Market The Icon Aesthetic System In China

  11/29/2016

• Cynosure Promotes Doug Delaney To Chief Commercial Officer

  11/1/2016

• Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent From Prior Year To $106.4 Million

  10/25/2016